Research Protocol

BPC-157 - Research Protocol

Quickstart Highlights

Reconstitution Summary
BPC-157 is supplied as a sterile, lyophilized peptide intended for laboratory research. It is commonly reconstituted with bacteriostatic water before use in research settings.

Typical Research Concentration
The final concentration depends on the volume of diluent selected for the research protocol.

Easy Measuring Note
Once reconstituted, the solution concentration is determined by the amount of diluent added. Researchers should calculate concentrations before preparing experimental solutions.

Storage

  • Store unreconstituted vials in a cool, dry location away from direct light.
  • After reconstitution, refrigerate according to laboratory best practices.
  • Avoid repeated freeze-thaw cycles.
  • Discard if the solution becomes cloudy or contains visible particles.

Dosing & Reconstitution Guide

Phase Dose Units (per injection) Vials needed
Research Preparation Varies by Research Protocol Varies 1 vial (10 mg)

Supplies Needed

  • BPC-157 10 mg vial
  • Bacteriostatic Water
  • Sterile syringes
  • Alcohol prep swabs
  • Protective laboratory equipment
  • Sharps disposal container

Protocol Overview

BPC-157 is a synthetic peptide commonly investigated in preclinical research involving tissue repair, angiogenesis, gastrointestinal integrity, and cellular signaling. Before laboratory use, the lyophilized powder is reconstituted with a sterile diluent to create a research solution of the desired concentration.

Research procedures should follow appropriate laboratory protocols, including aseptic handling, accurate concentration calculations, and proper storage of reconstituted materials.

How It Works

BPC-157 is a synthetic peptide derived from a sequence found in human gastric juice. In laboratory and animal studies, it has been investigated for its interactions with biological pathways involved in:

  • Tissue repair and regeneration
  • Angiogenesis (formation of new blood vessels)
  • Nitric oxide signaling
  • Collagen synthesis
  • Tendon and ligament healing mechanisms
  • Gastrointestinal mucosal protection
  • Inflammatory signaling pathways

Although these findings have generated scientific interest, evidence in humans remains limited, and BPC-157 has not been approved by the U.S. Food and Drug Administration for the diagnosis, treatment, cure, or prevention of any disease.

Potential Benefits & Side Effects

Preclinical studies have explored BPC-157 in relation to:

  • Soft tissue healing
  • Tendon and ligament research
  • Muscle regeneration
  • Gastrointestinal tissue integrity
  • Angiogenesis
  • Cellular repair mechanisms
  • Inflammatory pathway research

These represent areas of scientific investigation and should not be interpreted as established therapeutic uses.

Safety Information

Human safety has not been established through FDA approval. Published human data remain limited.

Potential risks include:

  • Unknown long-term safety profile
  • Product contamination if not handled aseptically
  • Local irritation associated with research administration procedures
  • Risks inherent to improper preparation or handling

Use appropriate laboratory safety practices and comply with applicable regulations.


For laboratory and research use only. Minimum 98% purity. Not intended for human or animal consumption, medical, diagnostic, therapeutic or veterinary use. These statements have not been evaluated by the MHRA or FDA. This protocol is provided for educational and research purposes only and is not medical advice. The purchaser accepts full responsibility for safe handling, storage and lawful use.